Overview of Dr. Russo
Dr. Paul Russo is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 38 years. He is one of 76 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Cancer Biology, 1986 - 1988- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1984 - 1988
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1981 - 1984- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1979 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
NJ State Medical License 2021 - 2025
NY State Medical License 1988 - 2025
CT State Medical License 2023 - 2024- American Board of Urology Urology
Awards, Honors, & Recognition
- New York City Best Doctors Castle Connelly, 2000-2016
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma.Patrick T Bradshaw, Linnea T Olsson, Alejandro Sanchez, Andrea Knezevic, Oguz Akin
Cancer Epidemiology, Biomarkers & Prevention. 2024-10-02 - Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 9...Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli
Journal of Clinical Oncology. 2024-09-20 - Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal Disease.Lennert Eismann, Mark Zucker, Mark T Dawidek, Stephen W Reese, Lina Posada Calderon
Urology Practice. 2024-09-01
Journal Articles
- Importance of Wide Re‐Resection in Adult Spermatic Cord Sarcomas: Report on Oncologic Outcomes at a Single InstitutionMassimiliano Spaliviero, Kaled M Alektiar, Harry W Herr, Paul Russo, Journal of Surgical Oncology
- Analysis of Renal Cancer Cell Lines from Two Major Resources Enables Genomics-Guided Cell Line SelectionSatish K Tickoo, Paul Russo, A Ari Hakimi, Victor E Reuter, James J Hsieh, Jonathan A Coleman, Michael Chevinsky, Christopher Jakubowski, Andrew G Winer, Nature
Authored Content
- Minerva Urologica E Nefrologica 2017 December;69(6):539-47August 2018
Press Mentions
Study Shows No Link Between Race and Mortality in Clear Cell RCCDecember 17th, 2020- PN Risks May Outweigh Benefits in Some CKD CasesSeptember 3rd, 2020
Does Cytoreductive Nephrectomy Remain an Essential Component of Care for Advanced Renal Cell Carcinoma?June 25th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Urological OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
